Recruitment of human cyclin T1 to nuclear bodies through direct interaction with the PML protein

Human cyclin T1, the cyclin partner of Cdk9 kinase in the positive transcription elongation factor b (P‐TEFb), is an essential cellular cofactor that is recruited by the human immunodeficiency virus type 1 (HIV‐1) Tat transactivator to promote transcriptional elongation from the HIV‐1 long terminal repeat (LTR). Here we exploit fluorescence resonance energy transfer (FRET) to demonstrate that cyclin T1 physically interacts in vivo with the promyelocytic leukaemia (PML) protein within specific subnuclear compartments that are coincident with PML nuclear bodies. Deletion mutants at the C‐terminal region of cyclin T1 are negative for FRET with PML and fail to localize to nuclear bodies. Cyclin T1 and PML are also found associated outside of nuclear bodies, and both proteins are present at the chromatinized HIV‐1 LTR promoter upon Tat transactivation. Taken together these results suggest that PML proteins regulate Tat‐ mediated transcriptional activation by modulating the availability of cyclin T1 and other essential cofactors to the transcription machinery.

[1]  M. Carmo-Fonseca.  The Contribution of Nuclear Compartmentalization to Gene Regulation , 2002, Cell.

[2]  R. Eils,et al.  Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus , 2002, Nature Cell Biology.

[3]  B. Peterlin,et al.  Interaction between P-TEFb and the C-Terminal Domain of RNA Polymerase II Activates Transcriptional Elongation from Sites Upstream or Downstream of Target Genes , 2002, Molecular and Cellular Biology.

[4]  P. Farnham,et al.  c-Myc Mediates Activation of the cad Promoter via a Post-RNA Polymerase II Recruitment Mechanism* , 2001, The Journal of Biological Chemistry.

[5]  Tamás Kiss,et al.  7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes , 2001, Nature.

[6]  Qiang Zhou,et al.  The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription , 2001, Nature.

[7]  T. Regad,et al.  Role and fate of PML nuclear bodies in response to interferon and viral infections , 2001, Oncogene.

[8]  G. Maul,et al.  Cellular proteins localized at and interacting within ND10/PML nuclear bodies/PODs suggest functions of a nuclear depot , 2001, Oncogene.

[9]  A. Dejean,et al.  SUMO: of branched proteins and nuclear bodies , 2001, Oncogene.

[10]  P. Freemont,et al.  PML protein isoforms and the RBCC/TRIM motif , 2001, Oncogene.

[11]  R. Everett,et al.  DNA viruses and viral proteins that interact with PML nuclear bodies , 2001, Oncogene.

[12]  M. Giacca,et al.  Visualization of in Vivo Direct Interaction between HIV-1 TAT and Human Cyclin T1 in Specific Subcellular Compartments by Fluorescence Resonance Energy Transfer* , 2001, The Journal of Biological Chemistry.

[13]  M J Sternberg,et al.  PML bodies associate specifically with the MHC gene cluster in interphase nuclei. , 2001, Journal of cell science.

[14]  Richard N. Day,et al.  Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleus. , 2001, Methods.

[15]  B. Peterlin,et al.  NF-κB Binds P-TEFb to Stimulate Transcriptional Elongation by RNA Polymerase II , 2001 .

[16]  Paul Freemont,et al.  Role of Promyelocytic Leukemia (Pml) Sumolation in Nuclear Body Formation, 11s Proteasome Recruitment, and as2O3-Induced Pml or Pml/Retinoic Acid Receptor α Degradation , 2001, The Journal of experimental medicine.

[17]  M. Mancini,et al.  The Cdk9 and cyclin T subunits of TAK/P-TEFb localize to splicing factor-rich nuclear speckle regions. , 2001, Journal of cell science.

[18]  F. Boisvert,et al.  The Transcription Coactivator Cbp Is a Dynamic Component of the Promyelocytic Leukemia Nuclear Body , 2001, The Journal of cell biology.

[19]  M. Giacca,et al.  Multiple Modes of Transcriptional Regulation by the HIV‐1 Tat Transactivator , 2001, IUBMB life.

[20]  M. Giacca,et al.  Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans* , 2001, The Journal of Biological Chemistry.

[21]  T Misteli,et al.  Protein dynamics: implications for nuclear architecture and gene expression. , 2001, Science.

[22]  L. Szekely,et al.  Proteins associated with the promyelocytic leukemia gene product (PML)-containing nuclear body move to the nucleolus upon inhibition of proteasome-dependent protein degradation. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Spector,et al.  Visualization of gene activity in living cells , 2000, Nature Cell Biology.

[24]  M. Giacca,et al.  Adeno-Associated Virus Type 2 Rep Protein Inhibits Human Papillomavirus Type 16 E2 Recruitment of the Transcriptional Coactivator p300 , 2000, Journal of Virology.

[25]  Paul R. Selvin,et al.  The renaissance of fluorescence resonance energy transfer , 2000, Nature Structural Biology.

[26]  Y. Fong,et al.  Relief of Two Built-In Autoinhibitory Mechanisms in P-TEFb Is Required for Assembly of a Multicomponent Transcription Elongation Complex at the Human Immunodeficiency Virus Type 1 Promoter , 2000, Molecular and Cellular Biology.

[27]  G. Stein,et al.  Intranuclear trafficking of transcription factors: implications for biological control. , 2000, Journal of cell science.

[28]  M. Montminy,et al.  Creb-Binding Protein (Cbp/P300) and RNA Polymerase II Colocalize in Transcriptionally Active Domains in the Nucleus , 2000, The Journal of cell biology.

[29]  J. Manley,et al.  RNA polymerase II and the integration of nuclear events. , 2000, Genes & development.

[30]  Pier Paolo Pandolfi,et al.  The transcriptional role of PML and the nuclear body , 2000, Nature Cell Biology.

[31]  T. Misteli,et al.  High mobility of proteins in the mammalian cell nucleus , 2000, Nature.

[32]  D. Price.  P-TEFb, a Cyclin-Dependent Kinase Controlling Elongation by RNA Polymerase II , 2000, Molecular and Cellular Biology.

[33]  François-Michel Boisvert,et al.  Promyelocytic Leukemia (Pml) Nuclear Bodies Are Protein Structures That Do Not Accumulate RNA , 2000, The Journal of cell biology.

[34]  M. Garber,et al.  HIV-1 Tat: coping with negative elongation factors. , 1999, Current opinion in immunology.

[35]  R. Evans,et al.  Modulation of CREB binding protein function by the promyelocytic (PML) oncoprotein suggests a role for nuclear bodies in hormone signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  B. Cullen,et al.  Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV‐1 Tat , 1998, The EMBO journal.

[37]  M. Garber,et al.  The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. , 1998, Genes & development.

[38]  M. Giacca,et al.  HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[39]  K. Jeang,et al.  Activation of Integrated Provirus Requires Histone Acetyltransferase , 1998, The Journal of Biological Chemistry.

[40]  B. Peterlin,et al.  The Ability of Positive Transcription Elongation Factor b To Transactivate Human Immunodeficiency Virus Transcription Depends on a Functional Kinase Domain, Cyclin T1, and Tat , 1998, Journal of Virology.

[41]  D. Chen,et al.  Transcription elongation factor P‐TEFb mediates Tat activation of HIV‐1 transcription at multiple stages , 1998, The EMBO journal.

[42]  J. Milton,et al.  Identification of multiple cyclin subunits of human P-TEFb. , 1998, Genes & development.

[43]  Ping Wei,et al.  A Novel CDK9-Associated C-Type Cyclin Interacts Directly with HIV-1 Tat and Mediates Its High-Affinity, Loop-Specific Binding to TAR RNA , 1998, Cell.

[44]  L. Zentilin,et al.  Fine mapping of a replication origin of human DNA. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[45]  M. Giacca,et al.  In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1 , 1993, Journal of virology.

[46]  L. Zentilin,et al.  A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. , 1992, Gene.

[47]  D. Price,et al.  Control of formation of two distinct classes of RNA polymerase II elongation complexes , 1992, Molecular and cellular biology.

[48]  J. Justement,et al.  Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. , 1988, Journal of immunology.

[49]  Andrea H. Brand,et al.  Imaging into the future: visualizing gene expression and protein interactions with fluorescent proteins , 2002, Nature Cell Biology.

[50]  P. Pandolfi,et al.  Role of PML and PML-RARalpha in Mad-mediated transcriptional repression. , 2001, Molecular cell.

[51]  B. Peterlin,et al.  Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection. , 2000, Immunity.

[52]  G. Stein,et al.  COMMENTARY Intranuclear trafficking of transcription factors: implications for biological control , 2000 .

[53]  G. Nabel,et al.  Protein Coactivators P300 and Creb Binding Virus Type 1 Tat with the Transcriptional Interaction of Human Immunodeficiency , 1998 .

[54]  R. Everett,et al.  A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein , 1997, The EMBO journal.